Members |
targetComponentId |
disopyramidfosfat 100 mg, depåkapsel |
Disopyramide only product in oral dose form |
disopyramidfosfat 100 mg, depåtablett |
Disopyramide only product in oral dose form |
Disopyramide phosphate 150mg |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Disopyramide phosphate 150mg capsule |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
disopyramidfosfat 150 mg, kapsel med modifierad frisättning |
Disopyramide only product in oral dose form |
disopyramidfosfat 150 mg, depåkapsel |
Disopyramide only product in oral dose form |
sjukdom efter anatomisk lokalisation |
Disease |
Disorder involving the integument of fetus or newborn, NEC |
Disorder involving the integument of fetus OR newborn |
Disorder of amino acid transport |
Amino acid transport disorder |
Disorder of balance |
Impairment of balance (finding) |
Disorder of hemostasis |
Blood coagulation disorder |
Disorder of iris AND/OR ciliary body |
Disorder of uveal tract |
Disorder of pregnancy |
Disorder of pregnancy |
Disorder of skeletal muscle |
Disorder of skeletal muscle |
Disorder of transport, NEC |
Metabolic disorder of transport |
Dispensing of unlisted low vision aid |
Fitting and dispensing of spectacles |
Displaced tooth |
Displaced tooth |
Displacement - action |
Action |
dislokation, grad 1 |
Displacement |
dislokation, grad 2 |
Displacement |
dislokation, grad 3 |
Displacement |
Disproportion of other origin, NEC |
Disproportion between fetal head and pelvis |
upprivet episiotomisår |
Disruption of episiotomy wound in the puerperium (disorder) |
upprivet lacerationssårställe |
Disrupted wound |
dissekerande aneurysm i koronarartär |
Dissection of coronary artery (disorder) |
Disseminated paracoccidioidomycosis |
Disseminated paracoccidioidomycosis (disorder) |
distal interfalangealled i stortå, struktur |
Interphalangeal joint structure of great toe |
distal myopati med tidigt engagemang av andningsmuskler |
Hereditary myopathy with early respiratory failure |
Disto-occlusion |
Disto-occlusion of teeth |
Disturbance in form of thinking |
Disorder of form of thought |
ditranolkrämallergi |
Allergy to dithranol (finding) |
ditranolsalvaallergi |
Allergy to dithranol (finding) |
ditranolpastaallergi |
Allergy to dithranol (finding) |
divalproexnatrium 125 mg, tablett med fördröjd frisättning |
Product containing precisely valproic acid (as valproate semisodium) 125 milligram/1 each gastro-resistant oral tablet (clinical drug) |
divalproexnatrium 250 mg, tablett med fördröjd frisättning |
Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
divalproexnatrium 500 mg, tablett med modifierad frisättning |
Valproic acid only product in oral dose form |
divalproexnatrium 500 mg, depåtablett |
Valproic acid only product in oral dose form |
Diversional therapy |
Diversional therapy |
divisionen Tenericutes |
Phylum Tenericutes (organism) |
delning av palmaraponeuros vid kirurgisk behandling av Dupuytrens kontraktur |
Division of palmar aponeurosis for correction of Dupuytren contracture (procedure) |
dobutamin 12,5 mg/ml, infusionskoncentrat, flaska 20 ml |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dobutamin 50 mg/ml, infusionskoncentrat, ampull 5 ml |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
gör inte |
Does not |
vaccin mot hundallergi |
Dog allergy vaccine (product) |
Doll's eye sign |
Doll's head reflex |
Dolphin distemper virus |
Cetacean morbillivirus (organism) |
Domain Archaea |
Domain Archaea |
Domestic animal species, non-primate |
Class Mammalia (organism) |
Domestic animals |
Class Mammalia (organism) |
donepezil 10 mg, munsönderfallande tablett |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
donepezil 1mg/ml, oral lösning |
Donepezil hydrochloride 1 mg/mL oral solution |
donepezil 5 mg, munsönderfallande tablett |
Donepezil hydrochloride 5 mg orodispersible tablet |
dopaminhydroklorid 160 mg/ml, infusionskoncentrat, ampull 5 ml |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dopaminhydroklorid 40 mg/ml, infusionskoncentrat, ampull 5 ml |
Dopamine hydrochloride 40 mg/mL solution for injection |
dopexaminhydroklorid 10 mg/ml, infusionskoncentrat, ampull 5 ml |
Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dornase alfa 2500 E (2,5 mg), lösning för nebulisator |
Dornase alfa 1 mg/mL solution for inhalation |
Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
läkemedelsform, indelning efter den lokalisation som den har beretts för |
Pharmaceutical dose form (dose form) |
språkurval dosenhet singular, nationella läkemedelslistan |
Context-specific terms language type reference set, Swedish national medication list (foundation metadata concept) |
dotiepinhydroklorid 25 mg/5 ml, oralt elixir |
Dosulepin 5 mg/mL oral solution |
dotiepinhydroklorid 25 mg/5 ml, sockerfritt elixir |
Dosulepin 5 mg/mL oral solution |
dotiepinhydroklorid 75 mg/5 ml, oralt elixir |
Dosulepin 15 mg/mL oral solution |
dotiepinhydroklorid 75 mg/5 ml, sockerfritt elixir |
Dosulepin 15 mg/mL oral solution |
Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
Double - DT - vaccination |
Preschool administration of diphtheria and tetanus vaccine |
Downs inkontinensutrustning |
Incontinence appliance (physical object) |
Doxazosin mesylate 8mg tablet |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
doxepinhydroklorid 10 mg/ml, oral lösning |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Doxepin metabolite |
Product containing doxepin (medicinal product) |
doxorubicinhydroklorid 10 mg, injektionsvätska, lösning, flaska |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
doxorubicinhydroklorid 20 mg, injektionsvätska, lösning, flaska |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Doxorubicin liposomal 20mg/10ml injection |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
doxycyklin 100 mg, dispergerbar tablett |
Doxycycline 100 mg orodispersible tablet |
doxycyklin 40 mg, kapsel med modifierad frisättning |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
doxycyklin 75 mg, munsönderfallande tablett |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
doxycyklinkalcium 50 mg/5 ml, sirap |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
doxycyklinhyklat 10 %, subgingivalt system för läkemedelstillförsel |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
Doxycycline hyclate 200mg injection (pdr for recon) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
doxycyklinhyklat 200 mg, pulver till injektionsvätska, flaska |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
doxycyklinmonohydrat 25 mg/5 ml, suspension |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
Drain insertion - action |
Insertion - action (qualifier value) |
Drechslera longirostrata |
Exserohilum longirostratum |
Dressing - action |
Application - action |
torkad faktor IX-fraktion, upphettad, 600 IE, pulver och vätska till injektionslösning, flaska |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
torkad faktor IX-fraktion, upphettad, 600 IE, pulver till injektionsvätska, lösning, flaska |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Drimaren briljantgult |
Textile colours and finishes patch test substance |
drostanolonpropionatallergi |
Allergy to drostanolone (finding) |
drotrecogin alfa (aktiverat) 5 mg, pulver till infusionsvätska, lösning, flaska |
Drotrecogin alfa 5 mg powder for solution for injection vial |
drotrecogin alfa 20 mg, pulver till infusionsväska, lösning, flaska |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Drug |
Pharmaceutical / biologic product (product) |
Drug aerosol, 0,01% |
Drug aerosol |
Drug aerosol, 0,04% |
Drug aerosol |
Drug aerosol, 0,5% |
Drug aerosol |
Drug cream, 0,01% |
Cream |
Drug cream, 0,02% |
Cream |
Drug cream, 0,025% |
Cream |
Drug cream, 0,05% |
Cream |
Drug cream, 0,1% |
Cream |
Drug cream, 0,25% |
Cream |
Drug cream, 0,5% |
Cream |